source
- STAT+: More signs that GLP-1s may help with peripheral artery diseaseAnthropic will begin developing drugs, BridgeBio pockets a billion, and more biotech news from The Readout
- Upcoming FDA decisions in Q3 2026 could signal agency flexibilityThe piece highlights five FDA actions slated for the third quarter of 2026 that industry participants are tracking. Observers say the outcomes may reveal how flexible the agency will be under its…